日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance

HIV-1 对第五代蛋白酶抑制剂产生耐药性的选择揭示了两种独立的高水平耐药途径

Ean Spielvogel, Sook-Kyung Lee, Shuntai Zhou, Gordon J Lockbaum, Mina Henes, Amy Sondgeroth, Klajdi Kosovrasti, Ellen A Nalivaika, Akbar Ali, Nese Kurt Yilmaz, Celia A Schiffer, Ronald Swanstrom

HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues

具有 P1 膦酸酯修饰的 HIV-1 蛋白酶抑制剂通过增加与活瓣残基的相互作用来保持对抗耐药变体的效力

Gordon J Lockbaum, Linah N Rusere, Mina Henes, Klajdi Kosovrasti, Desaboini Nageswara Rao, Ean Spielvogel, Sook-Kyung Lee, Ellen A Nalivaika, Ronald Swanstrom, Nese Kurt Yilmaz, Celia A Schiffer, Akbar Ali

Inhibiting HTLV-1 Protease: A Viable Antiviral Target

抑制 HTLV-1 蛋白酶:可行的抗病毒靶点

Gordon J Lockbaum, Mina Henes, Nathaniel Talledge, Linah N Rusere, Klajdi Kosovrasti, Ellen A Nalivaika, Mohan Somasundaran, Akbar Ali, Louis M Mansky, Nese Kurt Yilmaz, Celia A Schiffer

Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance

皮摩尔到微摩尔:阐明 HIV-1 蛋白酶远端突变在赋予耐药性中的作用

Mina Henes, Gordon J Lockbaum, Klajdi Kosovrasti, Florian Leidner, Gily S Nachum, Ellen A Nalivaika, Sook-Kyung Lee, Ean Spielvogel, Shuntai Zhou, Ronald Swanstrom, Daniel N A Bolon, Nese Kurt Yilmaz, Celia A Schiffer

Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance

HIV-1 蛋白酶上位性的分子决定因素:阐明 L89V 和 L90M 突变在抗药性中的相互依赖性

Mina Henes, Klajdi Kosovrasti, Gordon J Lockbaum, Florian Leidner, Gily S Nachum, Ellen A Nalivaika, Daniel N A Bolon, Nese Kurt Yilmaz, Celia A Schiffer, Troy W Whitfield